552 related articles for article (PubMed ID: 34089819)
21. Strategies for Improving Bioavailability, Bioactivity, and Physical-Chemical Behavior of Curcumin.
Racz LZ; Racz CP; Pop LC; Tomoaia G; Mocanu A; Barbu I; Sárközi M; Roman I; Avram A; Tomoaia-Cotisel M; Toma VA
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296447
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of quercetin and resveratrol peptidyl derivatives as potential anticancer and antioxidant agents.
Mrkus L; Batinić J; Bjeliš N; Jakas A
Amino Acids; 2019 Feb; 51(2):319-329. PubMed ID: 30392096
[TBL] [Abstract][Full Text] [Related]
23. The potential role of resveratrol as supportive antiviral in treating conditions such as COVID-19 - A formulator's perspective.
van Brummelen R; van Brummelen AC
Biomed Pharmacother; 2022 Apr; 148():112767. PubMed ID: 35240527
[TBL] [Abstract][Full Text] [Related]
24. The therapeutic use of quercetin in ophthalmology: recent applications.
Zhao L; Wang H; Du X
Biomed Pharmacother; 2021 May; 137():111371. PubMed ID: 33561647
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol in disease prevention and health promotion: A role of the gut microbiome.
Chen X; Zhang J; Yin N; Wele P; Li F; Dave S; Lin J; Xiao H; Wu X
Crit Rev Food Sci Nutr; 2024; 64(17):5878-5895. PubMed ID: 36591813
[TBL] [Abstract][Full Text] [Related]
26. Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor.
Khodaei F; Ahsan A; Chamanifard M; Zamiri MJ; Ommati MM
J Biochem Mol Toxicol; 2020 Dec; 34(12):e22594. PubMed ID: 32770858
[TBL] [Abstract][Full Text] [Related]
27. Possible Mechanisms and Special Clinical Considerations of Curcumin Supplementation in Patients with COVID-19.
Heidari Z; Mohammadi M; Sahebkar A
Adv Exp Med Biol; 2021; 1308():127-136. PubMed ID: 33861442
[TBL] [Abstract][Full Text] [Related]
28. Immunomodulatory agents as potential therapeutic or preventive strategies for COVID-19.
Gaziano R; Pistoia ES; Campione E; Fontana C; Marino D; Favaro M; Pica F; Di Francesco P
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4174-4184. PubMed ID: 34156699
[TBL] [Abstract][Full Text] [Related]
29. Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives.
Dejani NN; Elshabrawy HA; Bezerra Filho CDSM; de Sousa DP
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439920
[TBL] [Abstract][Full Text] [Related]
30. Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms.
Marín-Palma D; Tabares-Guevara JH; Zapata-Cardona MI; Flórez-Álvarez L; Yepes LM; Rugeles MT; Zapata-Builes W; Hernandez JC; Taborda NA
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833991
[TBL] [Abstract][Full Text] [Related]
31. Health effects of quercetin: from antioxidant to nutraceutical.
Boots AW; Haenen GR; Bast A
Eur J Pharmacol; 2008 May; 585(2-3):325-37. PubMed ID: 18417116
[TBL] [Abstract][Full Text] [Related]
32. Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management.
Vargas AJ; Burd R
Nutr Rev; 2010 Jul; 68(7):418-28. PubMed ID: 20591109
[TBL] [Abstract][Full Text] [Related]
33. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
Chang R; Ng TB; Sun WZ
Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
[TBL] [Abstract][Full Text] [Related]
34. Topical application of phenolic compounds suppresses Propionibacterium acnes-induced inflammatory responses in mice with ear edema.
Dos Santos ZMQ; Dos Santos MQ; Zancanaro V; Bellaver EH; Nardi GM; Gelinski JML; Locatelli C
Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):529-540. PubMed ID: 30617549
[TBL] [Abstract][Full Text] [Related]
35. Bidirectional interactions between dietary curcumin and gut microbiota.
Shen L; Ji HF
Crit Rev Food Sci Nutr; 2019; 59(18):2896-2902. PubMed ID: 29781709
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties.
Asif M; Saleem M; Saadullah M; Yaseen HS; Al Zarzour R
Inflammopharmacology; 2020 Oct; 28(5):1153-1161. PubMed ID: 32803479
[TBL] [Abstract][Full Text] [Related]
37. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review.
Smail SW; Saeed M; Twana Alkasalias ; Khudhur ZO; Younus DA; Rajab MF; Abdulahad WH; Hussain HI; Niaz K; Safdar M
Food Chem Toxicol; 2021 Apr; 150():112087. PubMed ID: 33640537
[TBL] [Abstract][Full Text] [Related]
38. Probiotics and COVID-19: is there any link?
Akour A
Lett Appl Microbiol; 2020 Sep; 71(3):229-234. PubMed ID: 32495940
[TBL] [Abstract][Full Text] [Related]
39. The Bidirectional Interactions between Resveratrol and Gut Microbiota: An Insight into Oxidative Stress and Inflammatory Bowel Disease Therapy.
Hu Y; Chen D; Zheng P; Yu J; He J; Mao X; Yu B
Biomed Res Int; 2019; 2019():5403761. PubMed ID: 31179328
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
Ter Ellen BM; Dinesh Kumar N; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; Apperloo L; van Gosliga D; van den Berge M; Nawijn MC; van der Voort PHJ; Moser J; Rodenhuis-Zybert IA; Smit JM
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
